Immune-Modulation by Epidermal Growth Factor Receptor Inhibitors: Implication on Anti-Tumor Immunity in Lung Cancer

• Jin S. Im ,

  * E-mail: jim@mdanderson.org

  Affiliation Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America

  http://orcid.org/0000-0002-5249-1177

  ⨯
• Amanda C. Herrmann,

  Affiliation Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Chantale Bernatchez,

  Affiliation Department of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Cara Haymaker,

  Affiliation Department of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Jeffrey J. Molldrem,

  Affiliation Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Waun Ki Hong,

  Affiliation Department of Thoracic H&N Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Roman Perez-Soler

  Affiliation Division of Oncology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, United States of America

  ⨯